EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanoparticle Engineering in Modern Vaccinology: From Delivery Platforms to Immune-Programming Architectures

Andrey Bogoyavlenskiy, Vladimir Berezin iD, Madina Alexyuk, Pavel Alexyuk iD, Elmira Omirtayeva

Molecules · 2026

DOI: 10.3390/molecules31142501 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2026. Verfasst von Andrey Bogoyavlenskiy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research and Production Center for Microbiology and Virology, Almaty 050010, Kazakhstan. Hauptthemen laut MEDLINE: Vaccinology, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Republic of Kazakhstan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent advances in vaccinology have accelerated the shift from conventional live-attenuated and inactivated vaccines toward subunit and nucleic acid-based platforms. Although these next-generation vaccines offer improved safety, rapid adaptability, and manufacturing flexibility, their relatively low intrinsic immunogenicity often requires efficient adjuvants and delivery systems. Nanoparticle-based vaccine platforms have therefore emerged as versatile tools capable of protecting antigens, improving targeted delivery, and modulating both innate and adaptive immune responses. This review summarizes the major classes of nanovaccine platforms, including lipid and polymeric nanoparticles, self-assembling protein nanostructures such as virus-like particles and ferritin nanocages, saponin-based self-assembling complexes, and inorganic nanomaterials. Particular attention is given to how vaccine performance is determined not only by material composition but also by nanoparticle physicochemical properties, biodistribution, cellular uptake, and mechanisms of immune activation. We further discuss the major challenges limiting clinical translation, including scalable manufacturing, safety evaluation, quality control, regulatory requirements, and long-term biocompatibility. Finally, emerging strategies involving hybrid and personalized nanovaccine platforms are highlighted, illustrating how nanotechnology and immunoengineering are transforming vaccine development for both prophylactic and therapeutic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VaccinologyNanoparticlesHumansNanovaccinesAnimalsVaccine DevelopmentAdjuvants, ImmunologicDrug Delivery SystemsNanotechnologyAdjuvants, Vaccine

Stichwörter der Autor:innen

ISCOMsadjuvantsantigen displayimmunoengineeringlipid nanoparticlesnanovaccinesvirus-like particles (VLPs)

Substanzen

NanovaccinesAdjuvants, ImmunologicAdjuvants, Vaccine

Autor:innen und Institutionen

  • Research and Production Center for Microbiology and Virology, Almaty 050010, Kazakhstan.

ORCID-Profile: Vladimir Berezin, Pavel Alexyuk

Förderung

  • Ministry of Science and Higher Education of the Republic of Kazakhstan

Zitieren

APA

Bogoyavlenskiy, A., Berezin, V., Alexyuk, M., Alexyuk, P., & Omirtayeva, E. (2026). Nanoparticle Engineering in Modern Vaccinology: From Delivery Platforms to Immune-Programming Architectures. Molecules. https://doi.org/10.3390/molecules31142501

Vancouver

Bogoyavlenskiy A, Berezin V, Alexyuk M, Alexyuk P, Omirtayeva E. Nanoparticle Engineering in Modern Vaccinology: From Delivery Platforms to Immune-Programming Architectures. Molecules. 2026. doi:10.3390/molecules31142501

BibTeX
@article{Bogoyavlenskiy2026,
  author = {Bogoyavlenskiy, Andrey and Berezin, Vladimir and Alexyuk, Madina and Alexyuk, Pavel and Omirtayeva, Elmira},
  title = {Nanoparticle Engineering in Modern Vaccinology: From Delivery Platforms to Immune-Programming Architectures},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31142501}
}
Kostenlos starten →